Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.
Colón JM, Miranda JD Neural Regen. Res. 2016; 11 (8): 1208–1211. DOI: 10.4103/1673-5374.189164
Colón JM, Miranda JD Neural Regen. Res. 2016; 11 (8): 1208–1211. DOI: 10.4103/1673-5374.189164
Morales-Cruz M, Cruz-Montañez A, Figueroa CM, González-Robles T, Davila J, Inyushin M, Loza-Rosas SA, Molina AM, Muñoz-Perez L, Kucheryavykh LY, Tinoco AD, Griebenow K Mol. Pharm. 2016; 13 (8): 2844–2854. DOI: 10.1021/acs.molpharmaceut.6b00461
Martinez NA, Ayala AM, Martinez M, Martinez-Rivera FJ, Miranda JD, Silva WI J. Biol. Chem. 2016; 291 (23): 12208–12222. DOI: 10.1074/jbc.M116.730226
Molina AM, Morales-Cruz M, Benítez M, Berríos K, Figueroa CM, Griebenow K J. Nanomedicine Nanotechnol. 2016; 6 (3): 1–8. DOI: 10.4172/2157-7439.1000294
Ramos FM, Delgado-Vélez M, Ortiz ÁL, Báez-Pagán CA, Quesada O, Lasalde-Dominicci JA J. Neurovirol. 2016; 22 (3): 327–335. DOI: 10.1007/s13365-015-0401-8
Melendez RI, Roman C, Capo-Velez CM, Lasalde-Dominicci JA J. Neurovirol. 2016; 22 (3): 358–365. DOI: 10.1007/s13365-015-0403-6
Delgado-Peraza F, Ahn KH, Nogueras-Ortiz C, Mungrue IN, Mackie K, Kendall DA, Yudowski GA Mol. Pharmacol. 2016; 89 (6): 618–629. DOI: 10.1124/mol.115.103176
Pézier AP, Jezzini SH, Bacon JP, Blagburn JM PloS One. 2016; 11 (4): e0152211. DOI: 10.1371/journal.pone.0152211
Negrón LM, Díaz TL, Ortiz-Quiles EO, Dieppa-Matos D, Madera-Soto B, Rivera JM Langmuir ACS J. Surf. Colloids. 2016; 32 (10): 2283–2290. DOI: 10.1021/acs.langmuir.5b03946
Padilla-Morales LF, Colón-Sáez JO, González-Nieves JE, Quesada-González O, Lasalde-Dominicci JA Data Brief. 2016; 6 (Supplement C): 433–437. DOI: 10.1016/j.dib.2015.12.010